Shin Kong Wu Ho-Su Memorial Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Taipei Taiwan (1945)

Organization Overview

First Clinical Trial
2005
NCT03515252
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Dermatology, Shin Kong Wu Ho Su Memorial Hospital, | Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital | Shih Kong Wu Ho-Su Memorial Hospital | Shin Kong Wu Ho-Su Memorial Hospital | Shin Kong Wu Huo-Shih Memorial Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Cerebral Infarction (Phase 4)

Fever (Phase 2)

Head and Neck Neoplasms (Phase 2)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Lung Neoplasms (Phase 1)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Sarcoma (Phase 2)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 32